Cue Biopharma Inc CUE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
1.74quote price arrow up+0.10 (+6.10%)
Volume
273,167
52 week range
1.30 - 4.89
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.74
  • 52 Week High4.89
  • 52 Week High Date07/17/23
  • 52 Week Low1.30
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap84.639M
  • Shares Out48.64M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.98
  • YTD % Change-37.88

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.74
  • 52 Week High4.89
  • 52 Week High Date07/17/23
  • 52 Week Low1.30
  • 52 Week Low Date04/25/24
  • Market Cap84.639M
  • Shares Out48.64M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.98
  • YTD % Change-37.88

RATIOS/PROFITABILITY

  • EPS (TTM)-1.07
  • P/E (TTM)-1.63
  • Fwd P/E (NTM)-1.65
  • EBITDA (TTM)-50.80M
  • ROE (TTM)-117.50%
  • Revenue (TTM)7.02M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-711.84%
  • Debt To Equity (MRQ)23.99%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cue Biopharma Inc

 

Profile

MORE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its...
Frank Morich M.D., Ph.D.
Independent Chairman of the Board
Daniel Passeri J.D.
Chief Executive Officer, Director
Anish Suri Ph.D.
President, Chief Scientific Officer
Kerri-Ann Millar CPA
Chief Financial Officer
Address
40 Guest Street
Boston, MA
02135
United States

Top Peers

SYMBOLLASTCHG%CHG
LVTX
LAVA Therapeutics NV
2.76-0.07-2.47%
AFMD
Affimed NV
5.44+0.10+1.87%
CLSD
Clearside Biomedical Inc
1.31-0.01-0.76%
JAGX
Jaguar Health Inc
0.2867+0.0316+12.3873%
CRIS
Curis Inc
12.60-0.40-3.08%